人干扰素α2a

Records for this ingredient, by country (identity only).

ATC D06BB · 1 markets · 15 records

人干扰素α2a 1 markets · 15 records Forms
Filters
MarketCN 15

CN 15 records · 6 shown of 6 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04

  • 300 万IU per mL / per unit basis not statedinjection万复洛人干扰素α2a因特芬、Manufacturer: 长春生物制品研究所有限责任公司
  • 100 万IU per mL / per unit basis not statedinjection万复洛人干扰素α2a因特芬、Manufacturer: 长春生物制品研究所有限责任公司
  • 500 万IU per mL / per unit basis not statedinjection因特芬人干扰素α2aManufacturer: 长春生物制品研究所有限责任公司
  • 600 万IU per mL / per unit basis not statedinjection万复洛人干扰素α2a
  • 50 万IUsuppository长生德佳人干扰素α2a
  • 2 万IUtopicalManufacturer: 长春生物制品研究所有限责任公司 ×4

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.